New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells

An improved compound of pentagamavunone-1 (PGV-1), chemoprevention-curcumin analog 1.1 (CCA-1.1), has been synthesized and proven to have antiproliferative effects against breast cancer cells. This study is designed to investigate the potency of CCA-1.1 alone and in combination with doxorubicin (Dox...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Febri Wulandari, Muthi' Ikawati, Dhania Novitasari, Mitsunori Kirihata, Jun-ya Kato, Edy Meiyanto
Format: article
Langue:EN
Publié: Universitas Gadjah Mada 2020
Sujets:
Accès en ligne:https://doaj.org/article/9b3e16eefe9341d78d2a4662424780b0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!